Zurueck zur Suche

Reporte zur Charge UJ593AAA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CO 1 OH 1

VAERS 2363935

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ593AAA

gering
Staat
CO
Alter
-
Geschlecht
F
Eingang
09.07.2022
Impfdatum
21.06.2022
Beginn
21.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Single component of a two-component product administered

Symptomtext

pentacel was administered to a patient using only the dtap-ipv portion and not the hib component/ DTaP-IPV portion of PENTACEL being administered without the Hib component.with no reported adverse event; Initial information received on 22-Jun-2022 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 1 month few weeks old female patient who experienced pentacel was administered to a patient using only the dtap-ipv portion and not the hib component/ dtap-ipv portion of pentacel being administered without the hib component.with no reported adverse event while receiving vaccine diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine [Pentacel]. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. Concomitant medications included pneumococcal vaccine CONJ 13V (CRM197) (PREVNAR 13) and rotavirus vaccine live reassort ORAL 5V (ROTATEQ) both for Immunisation. On 21-Jun-2022, the patient received suspect diphtheria/tetanus/5 HYBRID AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine at a dose of 0.5 ml total (lot UJ593AAA, expiry date, strength: not reported) via intramuscular route in the left thigh for immunisation. On 21-Jun-2022, latency same day, pentacel was administered to a patient using only the dtap-ipv portion and not the hib component/ dtap-ipv portion of pentacel being administered without the hib component.with no reported adverse event (single component of a two-component product administered) following the administration of diphtheria/tetanus/5 HYBRID AC pertussis/IPV(MRC5)/HIB(PRP/T) VACCINE. Action taken: not applicable. Outcome Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2213471

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ593AAA

gering
Staat
OH
Alter
0,2
Geschlecht
F
Eingang
04.04.2022
Impfdatum
28.03.2022
Beginn
28.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product preparation issue

Symptomtext

DTAP-IPV liquid portion of the vaccine was already administered to the patient without mixing the Hib part with no reported adverse event; Initial information received on 29-Mar-2022 regarding an unsolicited valid non-serious case received by other health professional. This case involves an 8 week old female patient to whom DTAP-IPV liquid portion of the vaccine was already administered without mixing the HIB part with no reported adverse event while receiving vaccine Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(MRC5)/HIB(PRP/T) Vaccine [Pentacel]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Pneumococcal Vaccine Conj 7V (CRM197) (Prevnar) for Prophylactic vaccination. On 28-Mar-2022, the patient received Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(MRC5)/HIB(PRP/T) Vaccine (form, strength: unknown; lot UJ593AAA) via intramuscular route in unknown administration site as Immunization. On 28-Mar-2022 (latency: same day), the patient DTAP-IPV liquid portion of the vaccine was already administered to the patient without mixing the HIB part with no reported adverse event (product preparation issue). Action taken: Not applicable. Event outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-